financetom
Business
financetom
/
Business
/
Trade Desk Q3 Adjusted Earnings, Revenue Rise; Shares Drop After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trade Desk Q3 Adjusted Earnings, Revenue Rise; Shares Drop After Hours
Nov 6, 2025 1:28 PM

04:10 PM EST, 11/06/2025 (MT Newswires) -- Trade Desk ( TTD ) reported Q3 adjusted net income late Thursday of $0.45 per diluted share, up from $0.41 a year earlier.

Analysts polled by FactSet expected $0.44.

Revenue in the three months ended Sept. 30 rose to $739 million from $628 million a year earlier.

Analysts surveyed by FactSet expected $719.1 million.

The company expects Q4 revenue of at least $840 million. Analysts project $830.4 million.

The company's shares fell 2% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ryan Specialty's Board Approves Leadership Succession Plan
Ryan Specialty's Board Approves Leadership Succession Plan
Jul 1, 2024
08:16 AM EDT, 07/01/2024 (MT Newswires) -- Ryan Specialty Group Holdings (RYAN) said Monday that its board of directors has unanimously approved a leadership succession plan to be implemented on Oct. 1. Under the plan, Chairman and Chief Executive Officer, Patrick G. Ryan, will transition to the role of executive chairman, and Chairman and CEO of Ryan Turner Specialty, Timothy...
Neurocrine Biosciences Says US FDA Accepts NDAs With Priority Review for Adrenal Gland Disease Drug
Neurocrine Biosciences Says US FDA Accepts NDAs With Priority Review for Adrenal Gland Disease Drug
Jul 1, 2024
08:22 AM EDT, 07/01/2024 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Monday that the US Food and Drug Administration has accepted two New Drug Applications with Priority review designations for for crinecerfont, to treat children, adolescents, and adults with classic congenital adrenal hyperplasia. The company said the submitted applications for crinecerfont include a capsule formulation and an oral...
Bridger Aerospace Acquires FMS Aerospace for $20.6 Million
Bridger Aerospace Acquires FMS Aerospace for $20.6 Million
Jul 1, 2024
08:15 AM EDT, 07/01/2024 (MT Newswires) -- Bridger Aerospace Group Holdings ( BAER ) said Monday that it has acquired FMS Aerospace, a company that offers airframe modification and integration solutions to government and commercial clients, for $20.6 million. The company said the deal involved $17.51 million in equity, with a potential additional equity earn-out consideration of up to $3.09...
Fennec Pharmaceuticals Chief Operating Officer Adrian Haigh Steps Down
Fennec Pharmaceuticals Chief Operating Officer Adrian Haigh Steps Down
Jul 1, 2024
08:15 AM EDT, 07/01/2024 (MT Newswires) -- Fennec Pharmaceuticals ( FENC ) said Monday that Adrian Haigh stepped down as chief operating officer, effective June 30. The company is searching for a US-based COO, Fennec Chief Executive Rosty Raykov said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved